Charioteer specializes in the production of nucleoside antivirals and antipyretic analgesics, we are the largest producer of Naproxen and Acyclovir in China. Charioteer obtained Acyclovir COS in May 2004, Naproxen sodium FDA approval in July 2004, Naproxen FDA approval in January 2007. Integrated certification on ISO9001-ISO14001-OHSAS 18001 got in December 2004.
more >
Year of Establishment:
1988
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
N;
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
N;
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Western Europe,Australasia,Asia,Middle East,Africa
Advantage Description: